Yousef Al-shraideh in Peoria, Illinois

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 2001
The Primary Medical Specialty for Yousef Al-shraideh is listed as: Urology
Approximate Years of Experience: 23
PAC (PECOS ID)#: 8325296874
NPI #: 1184989915
NPI Created On: 07/09/2012
NPI Last Updated Listed as: 12/18/2023
Primary Taxonomy Code: 208800000X
License Number:
2012-0904
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Blue Cross Blue Shield
• Geisinger Health Plan
• UPMC Health Options, Inc.
• Geisinger Quality Options
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: Arabic.

Services and Procedures include:

1. Injection of urinary duct (ureter) for x-ray imaging
2. Insertion of indwelling bladder catheter
3. Bladder instillation of cancer preventive, inhibiting, or suppressive agent
4. Ultrasound measurement of bladder capacity after voiding
5. Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope
6. Insertion of catheter into urinary duct (ureter) using an endoscope
7. Biopsy of the bladder using an endoscope
8. Destruction of (less than 0.5 centimeters) growths of the bladder and bladder canal (urethra) using an endoscope
9. Destruction and/or removal of (0.5 to 2.0 centimeters) small growths of the bladder using an endoscope
10. Destruction and/or removal of (2.0 to 5.0 centimeters) medium growths of the bladder and bladder canal (urethra) using an endoscope
11. Destruction and/or removal of large growths of the bladder using an endoscope
12. Insertion of stent in urinary duct (ureter) using an endoscope
13. Crushing of stone in urinary duct (ureter) with stent using an endoscope
14. Electro-removal of prostate through bladder canal (urethra) with control of bleeding using an endoscope
15. Biopsy of prostate gland
16. Ultrasonic guidance imaging supervision and interpretation for insertion of needle
17. Automated urinalysis test
18. Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle
19. New patient office or other outpatient visit, typically 45 minutes
20. Established patient office or other outpatient visit, typically 15 minutes